Our findings not only deepen the understanding of lncRNA-mediated transcriptional regulation in CRC but also highlight the CRAT40-YBX1-RelA axis as a potential target for novel anti-metastatic therapies. Here, LINC02563 is linked to colorectal carcinoma.